提升前列腺MRI质量及其诊断影响:一项前瞻性质量改进项目
这项前瞻性研究纳入2023年3月至2024年3月间1328例接受前列腺MRI的患者,实施聚焦患者准备、方案标准化、技师教育和质量控制的质量改进项目,并用PI-QUAL系统前瞻性评分图像质量。干预后PI-QUAL≥4的检查比例从67%升至84%(p<0.001),任何前列腺癌的阳性预测值从65%升至78%(p=0.03),但临床显著前列腺癌的阳性预测值从42%升至46%未达统计学显著(p=0.5)。
要点
- 质量改进项目使PI-QUAL≥4的检查比例从67%升至84%(p<0.001)。
- 任何前列腺癌的阳性预测值从65%升至78%(p=0.03)。
- 临床显著前列腺癌阳性预测值从42%升至46%,差异未达统计学显著(p=0.5)。
核心结论
- 质量改进项目显著提升了图像质量和总体癌症检出率,但图像质量与临床显著前列腺癌检出之间的关联未达统计学显著。
研究设计与样本
- 前瞻性质量改进研究,纳入1328例在2023年3月至2024年3月间接受前列腺MRI的患者,以PI-QUAL系统前瞻性评分图像质量,以Gleason分级分组≥2定义临床显著前列腺癌,采用Fisher精确检验比较阳性预测值。
诊断标准与关键数值
- 图像质量以PI-QUAL评分,PI-QUAL≥4为最佳质量;干预后PI-QUAL≥4的检查比例从67%升至84%(p<0.001)。
- 任何前列腺癌的阳性预测值在干预后从65%升至78%(p=0.03)。
- 临床显著前列腺癌(Gleason分级分组≥2)的阳性预测值在干预后从42%升至46%,差异未达统计学显著(p=0.5)。
- 最佳质量(PI-QUAL≥4)与次优质量检查之间,任何癌症的阳性预测值为76% vs. 77%(p=0.9),临床显著前列腺癌为45% vs. 48%(p=0.7),均无显著差异。
局限性
- 图像质量与临床显著前列腺癌检出之间的关联未达统计学显著,原文认为可能部分源于T2加权图像较扩散加权图像的改善更大以及阅片者经验丰富。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: High-quality imaging is critical for accurate prostate cancer assessment using MRI. This study describes a quality improvement (QI) initiative for prostate MRI and evaluates the impact of image quality on diagnostic performance.
METHODS: In this prospective study, 1328 patients underwent prostate MRI between March 2023 and March 2024. The QI initiative focused on patient preparation, protocol standardization, technologist education, and quality control. Image quality was prospectively scored using the Prostate Imaging Quality (PI-QUAL) system. Diagnostic performance was assessed by comparing the positive predictive value (PPV) of PI-RADS ≥ 3 lesions before and after the intervention and between exams with optimal (PI-QUAL ≥ 4) and suboptimal quality. Fisher's exact test was used for comparisons. Clinically significant prostate cancer (csPCa) was defined as Gleason Grade Group ≥ 2.
RESULTS: The proportion of PI-QUAL ≥ 4 exams increased from 67 to 84% after the intervention (p < 0.001). The PPV for any prostate cancer improved from 65 to 78% (p = 0.03), though the increase for csPCa (from 42 to 46%) was not statistically significant (p = 0.5). No significant difference in PPV was observed between optimal and suboptimal exams for any cancer (76% vs. 77%, p = 0.9) or csPCa (45% vs. 48%, p = 0.7).
CONCLUSION: The QI initiative significantly improved image quality and overall cancer detection rates. However, the association between image quality and csPCa detection was not statistically significant, possibly due to greater improvements in T2-weighted images vs. diffusion weighted images and high reader expertise.
引用
- Knott E, Bullen J, Harris R, et al. Improving prostate MRI quality and its diagnostic impact: a prospective quality improvement initiative. Abdom Radiol (NY). 2025. PMID: 40439721. doi:10.1007/s00261-025-05011-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。